Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

• 25 March 2005
• journal article
• Published by Elsevier in The Lancet
• Vol. 365  (9464) , 1054-1061
• https://doi.org/10.1016/s0140-6736(05)74230-6

Abstract

Keywords

• JAK2
• MYELOPROLIFERATIVE DISORDERS
• ERYTHROID
• VAL617PHE
• TREATMENT
• ACQUIRED MUTATION
• TYROSINE
• THROMBOCYTHAEMIA